Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation

Colleen M. Feltmate, Jozsef Batorfi, V. Fülöp, Donald P. Goldstein, Jozsef Doszpod, Ross S. Berkowitz

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

OBJECTIVE: To determine how often patients with molar pregnancy do not complete recommended follow-up and to identify factors that may predict failure to complete human chorionic gonadotropin (hCG) monitoring. This study also sought to determine how often patients with molar pregnancy who do not complete follow-up relapse after attaining at least one undetectable hCG value. METHODS: Four hundred randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels after molar evacuation. Demographic factors were determined for each patient: age, marital status, gravidity, parity, health insurance type, and distance from patient residence to trophoblastic center. RESULTS: Recommended hCG follow-up was completed in 63% of the uncomplicated 333 cases (n = 211). Three hundred twenty patients achieved at least one undetectable serum hCG level. Among the 320 patients, 33% achieved undetectable hCG values but did not complete recommended follow-up. However, none had any evidence of relapse. A distance of greater than 20 miles from the patient's residence to our center was associated with failure to complete hCG follow-up (P = .001). CONCLUSION: Because none of the 320 patients who achieved at least one undetectable hCG level has been diagnosed with gestational trophoblastic tumor relapse, it may be appropriate to reassess the duration of hCG monitoring for patients with molar pregnancy.

Original languageEnglish
Pages (from-to)732-736
Number of pages5
JournalObstetrics and Gynecology
Volume101
Issue number4
DOIs
Publication statusPublished - Apr 1 2003

Fingerprint

Hydatidiform Mole
Chorionic Gonadotropin
Recurrence
Trophoblastic Neoplasms
Gravidity
Marital Status
Physiologic Monitoring
Health Insurance
Parity
Serum
Demography

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Human chorionic gonadotropin follow-up in patients with molar pregnancy : A time for reevaluation. / Feltmate, Colleen M.; Batorfi, Jozsef; Fülöp, V.; Goldstein, Donald P.; Doszpod, Jozsef; Berkowitz, Ross S.

In: Obstetrics and Gynecology, Vol. 101, No. 4, 01.04.2003, p. 732-736.

Research output: Contribution to journalArticle

Feltmate, Colleen M. ; Batorfi, Jozsef ; Fülöp, V. ; Goldstein, Donald P. ; Doszpod, Jozsef ; Berkowitz, Ross S. / Human chorionic gonadotropin follow-up in patients with molar pregnancy : A time for reevaluation. In: Obstetrics and Gynecology. 2003 ; Vol. 101, No. 4. pp. 732-736.
@article{2af98f880c5c48e2b759ee1b554c3539,
title = "Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation",
abstract = "OBJECTIVE: To determine how often patients with molar pregnancy do not complete recommended follow-up and to identify factors that may predict failure to complete human chorionic gonadotropin (hCG) monitoring. This study also sought to determine how often patients with molar pregnancy who do not complete follow-up relapse after attaining at least one undetectable hCG value. METHODS: Four hundred randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels after molar evacuation. Demographic factors were determined for each patient: age, marital status, gravidity, parity, health insurance type, and distance from patient residence to trophoblastic center. RESULTS: Recommended hCG follow-up was completed in 63{\%} of the uncomplicated 333 cases (n = 211). Three hundred twenty patients achieved at least one undetectable serum hCG level. Among the 320 patients, 33{\%} achieved undetectable hCG values but did not complete recommended follow-up. However, none had any evidence of relapse. A distance of greater than 20 miles from the patient's residence to our center was associated with failure to complete hCG follow-up (P = .001). CONCLUSION: Because none of the 320 patients who achieved at least one undetectable hCG level has been diagnosed with gestational trophoblastic tumor relapse, it may be appropriate to reassess the duration of hCG monitoring for patients with molar pregnancy.",
author = "Feltmate, {Colleen M.} and Jozsef Batorfi and V. F{\"u}l{\"o}p and Goldstein, {Donald P.} and Jozsef Doszpod and Berkowitz, {Ross S.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0029-7844(03)00009-7",
language = "English",
volume = "101",
pages = "732--736",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Human chorionic gonadotropin follow-up in patients with molar pregnancy

T2 - A time for reevaluation

AU - Feltmate, Colleen M.

AU - Batorfi, Jozsef

AU - Fülöp, V.

AU - Goldstein, Donald P.

AU - Doszpod, Jozsef

AU - Berkowitz, Ross S.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - OBJECTIVE: To determine how often patients with molar pregnancy do not complete recommended follow-up and to identify factors that may predict failure to complete human chorionic gonadotropin (hCG) monitoring. This study also sought to determine how often patients with molar pregnancy who do not complete follow-up relapse after attaining at least one undetectable hCG value. METHODS: Four hundred randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels after molar evacuation. Demographic factors were determined for each patient: age, marital status, gravidity, parity, health insurance type, and distance from patient residence to trophoblastic center. RESULTS: Recommended hCG follow-up was completed in 63% of the uncomplicated 333 cases (n = 211). Three hundred twenty patients achieved at least one undetectable serum hCG level. Among the 320 patients, 33% achieved undetectable hCG values but did not complete recommended follow-up. However, none had any evidence of relapse. A distance of greater than 20 miles from the patient's residence to our center was associated with failure to complete hCG follow-up (P = .001). CONCLUSION: Because none of the 320 patients who achieved at least one undetectable hCG level has been diagnosed with gestational trophoblastic tumor relapse, it may be appropriate to reassess the duration of hCG monitoring for patients with molar pregnancy.

AB - OBJECTIVE: To determine how often patients with molar pregnancy do not complete recommended follow-up and to identify factors that may predict failure to complete human chorionic gonadotropin (hCG) monitoring. This study also sought to determine how often patients with molar pregnancy who do not complete follow-up relapse after attaining at least one undetectable hCG value. METHODS: Four hundred randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels after molar evacuation. Demographic factors were determined for each patient: age, marital status, gravidity, parity, health insurance type, and distance from patient residence to trophoblastic center. RESULTS: Recommended hCG follow-up was completed in 63% of the uncomplicated 333 cases (n = 211). Three hundred twenty patients achieved at least one undetectable serum hCG level. Among the 320 patients, 33% achieved undetectable hCG values but did not complete recommended follow-up. However, none had any evidence of relapse. A distance of greater than 20 miles from the patient's residence to our center was associated with failure to complete hCG follow-up (P = .001). CONCLUSION: Because none of the 320 patients who achieved at least one undetectable hCG level has been diagnosed with gestational trophoblastic tumor relapse, it may be appropriate to reassess the duration of hCG monitoring for patients with molar pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0037380115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037380115&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(03)00009-7

DO - 10.1016/S0029-7844(03)00009-7

M3 - Article

C2 - 12681878

AN - SCOPUS:0037380115

VL - 101

SP - 732

EP - 736

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -